CANTAB-V

This brand name is authorized in Nigeria.

Active ingredients

The drug CANTAB-V contains one active pharmaceutical ingredient (API):

1	Clotrimazole UNII G07GZ97H65 - CLOTRIMAZOLE
	Clotrimazole acts against fungi by inhibiting ergosterol synthesis. Inhibition of ergosterol synthesis leads to structural and functional impairment of the fungal cytoplasmic membrane. Clotrimazole has a broad antimycotic spectrum of action in vitro and in vivo, which includes dermatophytes, yeasts, moulds, etc.
	Read more about Clotrimazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-2382	Tablet	Cantab-V Tablets TAB 100 mg 1 x 6's	Tablet CANTAB-V TABLETS CLOTRIMAZOLE USP 100MG EACH TABLET CONTAINS CLOTRIMAZOLE 100MG EXCIPIENTS Microcrystalline cellulose Pregelatinised maize starch Sodium hydrogen carbonate A4-2382 Drugs Imported Products 1X6 Prescription Only Medicine (POM) 19/01/2021 MAYGLOW PHARMACEUTICAL LIMITED, MBAUKWU STREET, FEGGE ONITSHA ANAMBRA 80331342 mayglowrange@yahoo.com Dupen Laboratories PVT Ltd, C/1-49&36, Degan Road Industrial Township-Vapi 396 195, India	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G01AF02	Clotrimazole	G Genito urinary system and sex hormones → G01 Gynecological antiinfectives and antiseptics → G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS → G01AF Imidazole derivatives
Discover more medicines within G01AF02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-2382